Related Experiment Video

Updated: Dec 4, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.7K

Can Glypican-6 Level Predict Ejection Fraction Decline After Myocardial Infarction?

Fatih Ozturk1, Adem Atici2, Hasan Ali Barman3

  • 1Department of Cardiology, 64162Faculty of Medicine, Yuzunci Yil University, Van, Turkey.

Angiology
|October 23, 2020
PubMed

Insights

Glypican-6 (GPC6) levels predict reduced left ventricular ejection fraction (LVEF) after myocardial infarction (MI). Lower GPC6 levels indicate better LVEF recovery in patients treated with percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiology
  • Biomarkers
  • Acute Coronary Syndromes

Background:

  • Acute coronary syndrome (ACS) management aims to prevent myocardial ischemia and complications.
  • Cardiac remodeling, particularly reduced left ventricular ejection fraction (LVEF), is a key concern post-myocardial infarction (MI).
  • Predictive biomarkers for cardiac remodeling after MI are crucial for guiding treatment strategies.

Purpose of the Study:

  • To evaluate the predictive value of glypican-6 (GPC6) for cardiac remodeling, specifically persistent low LVEF, after MI.
  • To assess GPC6 as a potential biomarker in patients undergoing percutaneous coronary intervention (PCI) for acute MI.

Main Methods:

  • Plasma GPC6 levels were measured at baseline in 276 patients with acute MI undergoing primary PCI.
  • Left ventricular ejection fraction (LVEF) was assessed at baseline and 6 months post-MI using transthoracic echocardiography.
  • Logistic regression analysis identified predictors of low LVEF at 6 months, including GPC6, N-terminal pro-brain natriuretic peptide (NT-proBNP), and SYNTAX Score 2.

Main Results:

  • Reduced LVEF persisted in 89 out of 276 patients (32%) at 6 months post-MI.
  • Significantly lower baseline GPC6, NT-proBNP, and high-sensitive troponin levels were observed in patients with improved LVEF compared to those with persistently low LVEF.
  • Logistic regression identified SYNTAX Score 2, GPC6, and NT-proBNP as independent predictors of low LVEF (P < .001 for GPC6 and NT-proBNP).

Conclusions:

  • Glypican-6 (GPC6) may serve as a valuable independent predictor for the development of low left ventricular ejection fraction (LVEF) after myocardial infarction (MI).
  • Baseline plasma GPC6 levels could aid in identifying patients at higher risk for impaired cardiac remodeling post-PCI for acute MI.
  • Further research is warranted to confirm the utility of GPC6 in clinical decision-making for ACS patients.

Keywords:
STEMIglypican-6left ventricular ejection fraction

More Related Videos

Histological Quantification of Chronic Myocardial Infarct in Rats09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

15.1K
Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.5K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
116
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
227
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
391
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
628
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
249
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
189